A.G.Bio-Systems Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 9.96 M
as on 16-11-2024
- Company Age 27 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.65 Cr
as on 16-11-2024
- Revenue -20.28%
(FY 2023)
- Profit -39.05%
(FY 2023)
- Ebitda 22.55%
(FY 2023)
- Net Worth 6.98%
(FY 2023)
- Total Assets 19.48%
(FY 2023)
About A.G.Bio-Systems
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 9.96 M.
The company currently has active open charges totaling ₹1.65 Cr.
Venkatasubbarao Potluri, Laxminarayana Praharaju, Anurag Praharaju, and One other member serve as directors at the Company.
- CIN/LLPIN
U51219TG1997PTC027638
- Company No.
027638
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Jul 1997
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at A.G.Bio-Systems?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Laxminarayana Praharaju  | Managing Director | 30-Jul-1997 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anurag Praharaju | Additional Director | 14-Aug-2020 | Current |
| Venkatasubbarao Potluri | Director | 30-Jul-1997 | Current |
| Rajyalakshmi Praharaju | Director | 30-Jul-1997 | Current |
Financial Performance of A.G.Bio-Systems.
A.G.Bio-Systems Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 20.28% decrease. The company also saw a substantial fall in profitability, with a 39.05% decrease in profit. The company's net worth moved up by a moderate rise of 6.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of A.G.Bio-Systems?
In 2023, A.G.Bio-Systems had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Arbor Life Sciences Private LimitedActive 8 years 2 months
Venkatasubbarao Potluri is a mutual person
- Revag Biosciences LimitedActive 20 years 5 months
Laxminarayana Praharaju, Anurag Praharaju and 1 more are mutual person
- Pherorovers Private LimitedActive 4 years 9 months
Laxminarayana Praharaju and Anurag Praharaju are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 06 Mar 2008 | ₹1.65 Cr | Open |
How Many Employees Work at A.G.Bio-Systems?
Unlock and access historical data on people associated with A.G.Bio-Systems, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of A.G.Bio-Systems, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped A.G.Bio-Systems's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
